Delivery Order SPE2DB22D6029-SPE2DB25FLVJF
- Not listed
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $54,620 under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel for the period of August 28-29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs of the U.S. military...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Paclitaxel Protein-Bound 100mg pharmaceutical product. This firm fixed-price delivery order, valued at $16,027.18, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,845.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Paclitaxel Protein-Bound 100mg on January 21, 2026, with an ultimate completion date of January 22, 2026. This is a non-set-aside competitive award with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $11,158.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Paclitaxel Protein-Bound 100mg on August 6, 2025, with completion scheduled for August 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,338.49 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on November 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,073.00 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on January 7, 2026. This firm fixed-price delivery order, designated as a non-set-aside competitive award, is scheduled for ultimate completion on January 8, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, PA. AmerisourceBergen Drug Corp operates as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,312.12 to AmerisourceBergen Drug Corp on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on November 17, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of November 18,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,048.50 to AmerisourceBergen Drug Corp for pharmaceutical products under a firm fixed price contract. The award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a child delivery order executed against a larger indefinite delivery vehicle. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,066.16 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVJFDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Docetaxel 160 mg/16 ml vials, with a ceiling value of $4,896.00. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 24, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of medical products and supplies available under this IDC, enabling rapid fulfillment of diverse medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 6/23/25 |